| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| oxytocin | Injection, solution | 10 IU/mL | Anticipated | Available | Manufacturing | 16/06/2024 |
| lacosamide | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 16/06/2024 |
| lacosamide | Tablet, film coated | 150 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 16/06/2024 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Unavailable | Manufacturing | 16/06/2024 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Anticipated | Available | Unexpected increase in consumer demand | 14/06/2024 |
| amoxicillin trihydrate~potassium clavulanate | Suspension, powder for | 28.7 mg/mL~7.45 mg/mL | Current | Limited Availability | Manufacturing | 14/06/2024 |
| midazolam | Injection, solution | 5 mg | Resolved | Available | Manufacturing | 14/06/2024 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Current | Unavailable | Manufacturing | 14/06/2024 |
| haloperidol | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 14/06/2024 |
| valganciclovir hydrochloride | Tablet, film coated | 496.3 mg | Resolved | Available | Manufacturing | 14/06/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/06/2024 |
| cerliponase alfa | Injection, solution | 30 mg/mL | Anticipated | Available | Manufacturing | 14/06/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 41.363 mg~10 mg | Current | Limited Availability | Manufacturing | 14/06/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 82.725 mg~10 mg | Current | Limited Availability | Manufacturing | 14/06/2024 |
| clindamycin phosphate | Injection, solution | 0 QS | Anticipated | Available | Manufacturing | 14/06/2024 |
| melphalan | Injection, powder for | 50 mg | Resolved | Available | Manufacturing | 14/06/2024 |
| medronic acid | Injection, powder for | 10 mg | Resolved | Available | Manufacturing | 13/06/2024 |
| Somatropin | Injection, powder for | 12 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 13/06/2024 |
| donepezil hydrochloride | Tablet, film coated | 5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 13/06/2024 |
| lercanidipine hydrochloride | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 13/06/2024 |
| drospirenone~ethinylestradiol | Tablet | 3 mg~30 microgram | Anticipated | Available | Manufacturing | 13/06/2024 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 13/06/2024 |
| Omalizumab | Injection, solution | 150 mg | Anticipated | Available | Manufacturing | 13/06/2024 |
| quetiapine fumarate | Tablet, film coated | 345.36 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 13/06/2024 |
| lisinopril dihydrate | Tablet, uncoated | QS | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 13/06/2024 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 45.4 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 13/06/2024 |
| sodium iodide(131I) | Oral Liquid, solution | 50 MBq | Resolved | Available | Manufacturing | 13/06/2024 |
| sodium iodide(131I) | Capsule, hard | 50 MBq | Resolved | Available | Manufacturing | 13/06/2024 |
| temozolomide | Capsule, hard | 5 mg | Current | Unavailable | Manufacturing | 13/06/2024 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 13/06/2024 |
| busulfan | Injection, concentrated | 60 mg | Current | Unavailable | Manufacturing | 13/06/2024 |
| levodopa~carbidopa monohydrate | Tablet, modified release | 200 mg~54 mg | Anticipated | Available | Manufacturing | 13/06/2024 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Unavailable | Manufacturing | 13/06/2024 |
| morphine sulfate pentahydrate | Tablet, film coated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 13/06/2024 |
| sodium iodide(131I) | Oral Liquid, solution | 1201 MBq | Resolved | Available | Manufacturing | 13/06/2024 |
| diltiazem hydrochloride | Capsule, modified release | 180 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 12/06/2024 |
| diltiazem hydrochloride | Capsule, modified release | 240 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 12/06/2024 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 12/06/2024 |
| levetiracetam | Tablet, film coated | 500 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| lomustine | Capsule, hard | 40 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/06/2024 |
| lomustine | Capsule, hard | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/06/2024 |
| quetiapine fumarate | Tablet, modified release | 460.52 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| lisinopril dihydrate | Tablet, uncoated | QS | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| rizatriptan benzoate | Tablet, orally disintegrating | 14.53 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| rizatriptan benzoate | Tablet, orally disintegrating | 14.53 mg | Current | Unavailable | Manufacturing | 12/06/2024 |
| enoxaparin sodium | Injection, solution | 60 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| timolol maleate | Eye Drops, solution | 6.84 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/06/2024 |
| disulfiram | Tablet, effervescent | 200 mg | Current | Unavailable | Manufacturing | 12/06/2024 |
| testosterone | Drug delivery system, transdermal | 24.3 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 12/06/2024 |
| baclofen | Tablet, uncoated | 25 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 12/06/2024 |
| famotidine | Tablet, film coated | 20 mg | Current | Unavailable | Manufacturing | 12/06/2024 |
| lisinopril dihydrate | Tablet, uncoated | 10.89 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| povidoneiodine | Application | 100 mg/mL | Current | Unavailable | Manufacturing | 11/06/2024 |
| isoniazid | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 11/06/2024 |
| levetiracetam | Tablet, film coated | 250 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| levetiracetam | Tablet, film coated | 1000 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| prochlorperazine maleate | Tablet | 5 mg | Anticipated | Available | Commercial Changes / Commercial viability | 11/06/2024 |
| metoprolol succinate | Tablet, modified release | 190 mg | Resolved | Available | Manufacturing | 11/06/2024 |
| rabeprazole sodium | Tablet, enteric coated | 20 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| zolmitriptan | Tablet, film coated | 2.5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| methotrexate | Injection, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 11/06/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, multilayer | 86.8 mg~10 mg | Current | Unavailable | Manufacturing | 11/06/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| cisplatin | Injection, concentrated | 1 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 11/06/2024 |
| atomoxetine hydrochloride | Capsule, hard | 45.5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| sorbitol~activated charcoal | Suspension | .283 g/mL~.2 g/mL | Resolved | Available | Manufacturing | 11/06/2024 |
| lidocaine hydrochloride | Injection, solution | 400 mg | Current | Unavailable | Manufacturing | 11/06/2024 |
| Teriparatide | Injection, solution | 250 microgram/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/06/2024 |
| octreotide | Injection, solution | 50 microgram/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 11/06/2024 |
| heparin sodium | Injection, solution | 1000 IU/mL | Current | Limited Availability | Manufacturing | 11/06/2024 |
| olanzapine | Injection, powder for | 10 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 11/06/2024 |
| difelikefalin acetate | Injection, solution | 55 microgram | Anticipated | Available | Manufacturing | 10/06/2024 |
2024年6月17日